Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 69 results found. Search for [ remdesivir to treat coronavirus ]

Results 1 to 21 of 69
Reuters
November 20, 2020
The advice is another setback for the drug, which grabbed worldwide attention as a potentially effective treatment for COVID-19 in the summer after early trials showed some promise


BusinessToday.In
October 16, 2020
Ivermectin, a drug used to treat lice and other parasites, has shown some promising results against coronavirus, claims a specialist from Melbourne


Reuters
October 16, 2020
The American company said the data appeared inconsistent, the findings were premature and that other studies had validated the drug's benefits


Reuters
October 8, 2020
Several European countries have said they are experiencing shortages of the drug, whose global stock has been secured almost entirely by the United States


PTI
October 5, 2020
The intravenous antiviral drug, Remdesivir, is used to treat COVID-19


PTI
August 13, 2020
The drug discovery pipeline is a type of computational strategy linked to AI -- a computer algorithm that learns to predict activity through trial and error, improving over time


PB Jayakumar
August 13, 2020
Remdesivir price: Zydus is the fifth Indian company to launch the drug for coronavirus treatment after Hetero Labs, Cipla, Mylan NV and Jubilant Life Sciences. Priced at Rs 2,800 for a 100 mg lyophilized injection, its brand 'Remdac' will be the most economical


Reuters
August 13, 2020
Zydus has priced it at 2,800 rupees ($37.44) per 100mg vial. It will be sold under the brand name Remdac to government and private hospitals treating COVID-19 patients


Reuters
July 29, 2020
Drug, priced at Rs 59 per tablet, is approved to treat mild to moderate COVID-19 and will be available at drug stores from Wednesday, says Hetero


Prasanna Mohanty
July 27, 2020
Profit-driven enterprises are ill-suited to protect the health and life of a vast majority of people, as the US and Indian governments experience, but do precious little, thereby failing in their primary duty


BusinessToday.In
July 27, 2020
Avra Lab has developed an alternative low-cost and highly efficient manufacturing process and is now supplying commercial quantities to Cipla for the launch of Ciplenza, the generic version of Favipiravir


BusinessToday.In
July 24, 2020
Favipiravir, which is used to treat mild to moderate COVID-19 patients, will be commercially launched under the brand name Ciplenza in the first week of August, priced at Rs 68 per tablet


PTI
July 22, 2020
By understanding risk profiles and learning how to treat the disease, we've been able to greatly reduce mortality in the United States, Trump said


BusinessToday.In
July 13, 2020
Last month, Cipla introduced Remdesivir under the brand name 'CIPREMI' after receiving approval from DCGI for \"restricted emergency use\" on adult and paediatric patients hospitalised with suspected or laboratory-confirmed COVID-19 infection


Reuters
July 9, 2020
Remdesivir was granted emergency use authorization in the United States to treat severe cases of COVID-19 in patients who are hospitalized


PTI
July 8, 2020
\"The idea that this is a dangerous drug is just silly, but if you ask the American people based on the media's coverage of it, that is kind of the state of play right now,\" he said


BusinessToday.In
July 4, 2020
The drug has been making headlines with many health experts across the world recommending it for treatment of COVID-19. Remdesivir was originally used to treat Ebola patients


Reuters
July 4, 2020
A week ago, European Medicines Agency gave its go-ahead for remdesivir to be used in adults and adolescents from 12 years of age who are also suffering from pneumonia and require oxygen support


BusinessToday.In
July 1, 2020
Remdesivir supply: US Department of Health and Human Services said it has secured 500,000 treatment courses of remdesivir for American hospitals through September


PTI
July 1, 2020
Fujifilm is conducting a clinical study on Avigan to treat COVID-19 patients in Japan and the United States and has been seeking to increase the drug's production by partnering with domestic and overseas companies


PAGES 1 OF 4  1234